Water vs. gas: can a simple change make a key esophagus surgery safer?
NCT ID NCT07575295
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study compares two methods of preventing bleeding during a procedure called POEM, used to treat swallowing disorders. The standard method uses carbon dioxide gas, while the new method uses water to help seal blood vessels. Researchers will enroll 120 adults to see if the water technique reduces the need for extra tools to stop bleeding.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Underwater preventive coagulation (electrosurgical technique using water as conductive medium)
- What this could lead to
- If successful, this technique could make POEM safer and faster by reducing bleeding and the need for extra instruments.
- What could go wrong
- This is a small, early-stage trial (120 participants) testing a procedural tweak, not a new drug. The benefit may be modest or not reproducible in other centers.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 120 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Feb 2026
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
120 (60 in each arm)
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Age ≥ 18 years 2. Diagnosis of achalasia or esophageal motility disorder planned for POEM 3. Ability to provide informed consent Exclusion Criteria: 1. Anticoagulant or antithrombotic therapy not safely stoppable 2. Known coagulopathy or platelet disorder 3. Esophageal/gastric varices 4. Previous POEM or Heller's myotomy 5. Prior treatment for same condition 6. Inability or refusal to consent 7. Visualized vessels smaller than the HK inner diameter (1.2 mm)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Achalasia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Asian Institute of Gastroenterology Hospital
RECRUITINGHyderabad, Telangana, 500082, India
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could lying flat vs. on your side change esophageal test results?
- Nerve system glitches may worsen blood pressure swings during achalasia surgery — a study investigates
- New registry tracks POEM procedure for swallowing disorder
- New study investigates why some patients get worse reflux after esophagus surgery
- Small study seeks clues to weight loss mystery in achalasia
- Shingles virus in the gut linked to swallowing disorder – new trial aims to treat it